U.S. markets open in 3 hours 27 minutes

Vertex Pharmaceuticals Incorporated (VRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
208.44-3.62 (-1.71%)
At close: 4:00PM EST

206.56 -1.88 (-0.90%)
Pre-Market: 5:41AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close212.06
Open212.00
Bid205.10 x 800
Ask0.00 x 800
Day's Range208.06 - 213.27
52 Week Range197.47 - 306.08
Volume2,478,417
Avg. Volume1,938,128
Market Cap54.186B
Beta (5Y Monthly)0.63
PE Ratio (TTM)20.26
EPS (TTM)10.29
Earnings DateApr 27, 2021 - May 03, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est284.73
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
72% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Vertex (VRTX) Down 2.4% Since Last Earnings Report: Can It Rebound?
    Zacks

    Vertex (VRTX) Down 2.4% Since Last Earnings Report: Can It Rebound?

    Vertex (VRTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • 3 Growth Stocks That'll Make You Richer in March (and Beyond)
    Motley Fool

    3 Growth Stocks That'll Make You Richer in March (and Beyond)

    Back in 2016, Bank of America/Merrill Lynch issued a report that compared the performance of growth stocks to value stocks over a 90-year period (1926-2015). The results showed that value stocks were the superior choice (17% annual average return, versus 12.6% for growth stocks), albeit no investors are complaining with annual average returns of 12.6% or 17%. With lending rates at or near historic lows and the Federal Reserve remaining highly accommodative, growth stocks have run circles around value stocks for more than a decade.

  • Vertex to Present at the Cowen Health Care Conference on March 2
    Business Wire

    Vertex to Present at the Cowen Health Care Conference on March 2

    Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at the Cowen Health Care Conference on Tuesday, March 2, 2021 at 9:50 a.m. ET.